Organisation paid for research Program year 2025 Source: CMS Open Payments

Leavitt Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$723,429

174 payments

Through program year 2025, Leavitt Clinical Research is reported as receiving $723,429 in research payments, across 174 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $136,969 12
2024 Research $58,426 7
2023 Research $341,124 128
2022 Research $46,819 14
2021 Research $50,793 3
2020 Research $89,299 10

Breakdown

Who paid Research payments · program years 2020–2025
  1. Organon LLC $257,315 105 payments
  2. AbbVie, Inc. $139,677 16 payments
  3. Davol Inc. $102,753 4 payments
  4. Exeltis, USA Inc. $98,112 18 payments
  5. Abbott Laboratories $47,144 1 payment
  6. Ironwood Pharmaceuticals, Inc $27,994 12 payments
  7. C. R. Bard, Inc. & Subsidiaries $22,872 1 payment
  8. Sumitomo Pharma America, Inc. $17,720 9 payments
  9. Myovant Sciences GmbH $8,344 7 payments
  10. GlaxoSmithKline, LLC. $1,500 1 payment
Studies the money was for Research payments · program years 2020–2025
  1. Og-8175A-023 $168,921 97 payments
  2. Hem001 $99,172 3 payments
  3. LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women $98,112 18 payments
  4. Og-8175A-023 $88,393 8 payments
  5. M16-837 $83,268 9 payments
  6. Alinity m HR HPV Specimen Collection Study from Women Undergoing Routine Cervical cancer Screening $47,144 1 payment
  7. Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules;Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain $40,871 1 payment
  8. C3300-201 $27,994 12 payments
  9. Purest $22,872 1 payment
  10. A Phase 3, Single-Arm, Open-Label Study to Evaluate the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are 18 to 50 Years of Age and at Risk for Pregnancy $15,552 6 payments
What the money was spent on Research payments · program years 2020–2025
  1. Patient care $257,315 105 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record